Policy Roadmap for Medicines Manufacturing Leadership
Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns
COVID-19 “Round 2” – Findings & way forward (Kearney)
Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney
LESSONS LEARNED FROM COVID-19 – POLICY PAPER
Physicians recognised potential of Value Added Medicines
Position Paper. Reference safety information: challenges to the generic industry due to labelling harmonisation issues among different Member States
